A81.83

Clinical Causes: Genetic mutation in the PRNP gene encoding the prion protein Inheritance pattern is autosomal dominant, meaning a 50% chance of passing it on if a parent is affected The abnormal prion proteins accumulate in the brain, disrupting normal neural functions

Key Symptoms: Progressive insomnia that worsens over months to years Sleep disturbances including difficulty falling asleep or staying asleep Rapid eye movement (REM) sleep behavior disorder Anxiety, paranoia, and hallucinations Cognitive decline, memory loss, and confusion Difficulty concentrating and impaired judgment Muscle twitching and involuntary movements Feverish sensations or painful feelings without apparent cause Eventual physical deterioration, including loss of coordination and muscle weakness

Diagnosis Path: Diagnosing FFI involves a combination of clinical evaluation and laboratory tests. Medical professionals review the patient's family and medical history, especially noting any familial cases. Diagnostic tools may include: - **Polysomnography (sleep study):** To monitor sleep patterns and identify disturbances. - **Genetic testing:** To identify mutations in the PRNP gene associated with FFI. - **Brain imaging:** MRI scans might reveal specific changes in brain tissue, although findings can be nonspecific in early stages. - **Cerebrospinal fluid tests:** To examine for abnormal proteins and establish the presence of prion disease. Since definitive diagnosis often occurs post-mortem through brain tissue examination, early detection remains challenging.

Treatment Protocols: Currently, there is no cure for Fatal Familial Insomnia. Management strategies focus on alleviating symptoms and prolonging quality of life. Approaches include: - **Symptomatic treatment:** Use of medications to promote sleep, manage agitation, and control behavioral symptoms. - **Supportive care:** Ensuring nutritional support and protecting against injury due to physical deterioration. - **Genetic counseling:** For affected families to understand inheritance risks and implications. Research continues into potential therapies targeting prion proteins, but no approved treatments have been established to halt disease progression. Hospice and palliative care services are often involved as the disease advances to address complex medical needs and provide comfort.